vs
Side-by-side financial comparison of CBRE Group (CBRE) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
CBRE Group is the larger business by last-quarter revenue ($10.5B vs $5.5B, roughly 1.9× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 3.0%, a 4.9% gap on every dollar of revenue. On growth, CBRE Group posted the faster year-over-year revenue change (22.0% vs -0.3%).
CBRE can refer to:Canadian Brotherhood of Railway Employees, a railway trade union in Canada Chemical, Biological, Radiological and Explosive Defence Group, a counter-terrorism unit in Singapore CBRE Group, a multinational real estate corporation Certified broadcast radio engineer, a professional title regulated by The Society of Broadcast Engineers
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
CBRE vs FMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.5B | $5.5B |
| Net Profit | $318.0M | $434.2M |
| Gross Margin | 17.6% | 27.4% |
| Operating Margin | 4.9% | 11.7% |
| Net Margin | 3.0% | 7.9% |
| Revenue YoY | 22.0% | -0.3% |
| Net Profit YoY | 95.1% | 240.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $10.5B | — | ||
| Q4 25 | $11.5B | $5.5B | ||
| Q3 25 | $10.1B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $10.2B | $5.5B | ||
| Q3 24 | $8.8B | — | ||
| Q2 24 | $8.2B | — |
| Q1 26 | $318.0M | — | ||
| Q4 25 | $416.0M | $434.2M | ||
| Q3 25 | $363.0M | — | ||
| Q2 25 | $215.0M | — | ||
| Q1 25 | $163.0M | — | ||
| Q4 24 | $487.0M | $127.6M | ||
| Q3 24 | $225.0M | — | ||
| Q2 24 | $130.0M | — |
| Q1 26 | 17.6% | — | ||
| Q4 25 | 17.3% | 27.4% | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 17.1% | — | ||
| Q4 24 | 18.7% | 25.0% | ||
| Q3 24 | 18.1% | — | ||
| Q2 24 | 17.6% | — |
| Q1 26 | 4.9% | — | ||
| Q4 25 | 5.4% | 11.7% | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 5.8% | 5.1% | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 3.0% | — |
| Q1 26 | 3.0% | — | ||
| Q4 25 | 3.6% | 7.9% | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 4.8% | 2.3% | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.38 | — | ||
| Q3 25 | $1.21 | — | ||
| Q2 25 | $0.72 | — | ||
| Q1 25 | $0.54 | — | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $0.73 | — | ||
| Q2 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $1.7B |
| Total DebtLower is stronger | $5.1B | — |
| Stockholders' EquityBook value | $8.9B | $15.4B |
| Total Assets | $30.2B | $33.5B |
| Debt / EquityLower = less leverage | 0.57× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.9B | $1.7B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $928.0M | — |
| Q1 26 | $5.1B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $8.9B | — | ||
| Q4 25 | $8.9B | $15.4B | ||
| Q3 25 | $8.5B | — | ||
| Q2 25 | $8.3B | — | ||
| Q1 25 | $8.3B | — | ||
| Q4 24 | $8.4B | $17.0B | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.4B | — |
| Q1 26 | $30.2B | — | ||
| Q4 25 | $30.9B | $33.5B | ||
| Q3 25 | $28.6B | — | ||
| Q2 25 | $27.7B | — | ||
| Q1 25 | $26.4B | — | ||
| Q4 24 | $24.4B | $36.3B | ||
| Q3 24 | $24.8B | — | ||
| Q2 24 | $23.5B | — |
| Q1 26 | 0.57× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-825.0M | $2.9B |
| Free Cash FlowOCF − Capex | $-605.0M | — |
| FCF MarginFCF / Revenue | -5.7% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | -2.59× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-825.0M | — | ||
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $827.0M | — | ||
| Q2 25 | $57.0M | — | ||
| Q1 25 | $-546.0M | — | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $573.0M | — | ||
| Q2 24 | $287.0M | — |
| Q1 26 | $-605.0M | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $743.0M | — | ||
| Q2 25 | $-17.0M | — | ||
| Q1 25 | $-610.0M | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $494.0M | — | ||
| Q2 24 | $220.0M | — |
| Q1 26 | -5.7% | — | ||
| Q4 25 | 9.4% | — | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | -0.2% | — | ||
| Q1 25 | -7.0% | — | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 2.7% | — |
| Q1 26 | 0.8% | — | ||
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | -2.59× | — | ||
| Q4 25 | 2.94× | 6.67× | ||
| Q3 25 | 2.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | -3.35× | — | ||
| Q4 24 | 2.75× | 20.20× | ||
| Q3 24 | 2.55× | — | ||
| Q2 24 | 2.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
